Eugene J. Trybulski

1.6k citations

52 papers · 1.1k indexed · h-index 19

Co-authors: Joseph J. Tufariello Shaikh A. Ali G. B. MULLEN Robert J. Steffan E. J. Corey Paige E. Mahaney Robert Lett John R. Falck
Topics: Phenothiazines and Benzothiazines Synthesis and Activities (11 papers)Estrogen and related hormone effects (8 papers)Neurotransmitter Receptor Influence on Behavior (7 papers)
Cited by: Organic Chemistry Toxicology Pharmacology
Journals: Proceedings of the National Academy of Sciences Journal of the American Chemical Society Journal of Medicinal Chemistry
Partner nations: United States Canada Australia

In The Last Decade

Eugene J. Trybulski

52 papers receiving 1.1k citations

Peers

Countries citing papers authored by Eugene J. Trybulski

Since Specialization

Citations

This map shows the geographic impact of Eugene J. Trybulski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugene J. Trybulski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugene J. Trybulski more than expected).

Fields of papers citing papers by Eugene J. Trybulski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eugene J. Trybulski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugene J. Trybulski. The network helps show where Eugene J. Trybulski may publish in the future.

Co-authorship network of co-authors of Eugene J. Trybulski

This figure shows the co-authorship network connecting the top 25 collaborators of Eugene J. Trybulski. A scholar is included among the top collaborators of Eugene J. Trybulski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eugene J. Trybulski. Eugene J. Trybulski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Structure–activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores 2010 ·Bioorganic & Medicinal Chemistry Letters ·Andrew Fensome,Joel Goldberg,Casey C. McComas,Eugene J. Trybulski,(unknown),Darlene C. Deecher,Garth T. Whiteside,Puwen Zhang	7
2	1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as Potent and Selective Norepinephrine Reuptake Inhibitors 2010 ·Journal of Medicinal Chemistry ·A. T. Vu,(unknown),Puwen Zhang,(unknown),Paige E. Mahaney,Jenifer A. Bray,Grace H. Johnston,Elizabeth J. Koury,Scott Cosmi,Darlene C. Deecher,V. Anne Smith,James Harrison,Liza Leventhal,Garth T. Whiteside,Jeffrey D. Kennedy,Eugene J. Trybulski	19
3	Synthesis and evaluation of azabicyclo[3.2.1]octane derivatives as potent mixed vasopressin antagonists 2010 ·Bioorganic & Medicinal Chemistry Letters ·Aimee L. Crombie,(unknown),(unknown),David L. Crandall,Amedeo Failli,Yanan He,Jeffrey C. Kern,William Moore,Lisa Nogle,Eugene J. Trybulski	25
4	Structure–activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors 2009 ·Bioorganic & Medicinal Chemistry Letters ·Paige E. Mahaney,(unknown),(unknown),(unknown),(unknown),Christine Huselton,Eugene A. Terefenko,A. T. Vu,Puwen Zhang,Kevin D. Burroughs,Scott Cosmi,Jenifer A. Bray,Grace H. Johnston,Darlene C. Deecher,Eugene J. Trybulski	12
5	Modulation of Wnt signaling through inhibition of secreted frizzled-related protein I (sFRP-1) with N-substituted piperidinyl diphenylsulfonyl sulfonamides: Part II 2009 ·Bioorganic & Medicinal Chemistry ·William Moore,Jeffrey C. Kern,Ramesh A. Bhat,Peter V.N. Bodine,(unknown),Girija Krishnamurthy,Ronald L. Magolda,Keith Pitts,(unknown),Eugene J. Trybulski	18
6	Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols 2009 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Paige E. Mahaney,Oliver J. McConnell,Yingru Zhang,Eric S. Manas,Douglas M. Ho,Darlene C. Deecher,Eugene J. Trybulski	12
7	3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors 2009 ·Bioorganic & Medicinal Chemistry Letters ·A. T. Vu,(unknown),Eugene A. Terefenko,William Moore,Puwen Zhang,Paige E. Mahaney,Eugene J. Trybulski,Igor Goljer,(unknown),Jenifer A. Bray,Grace H. Johnston,(unknown),Darlene C. Deecher	18
8	5-Aryl indanones and derivatives as non-steroidal progesterone receptor modulators 2009 ·Bioorganic & Medicinal Chemistry Letters ·Jeffrey C. Kern,Eugene A. Terefenko,Eugene J. Trybulski,Thomas J. Berrodin,Jeffrey Cohen,Richard C. Winneker,Matthew R. Yudt,Zhiming Zhang,Yuan Zhu,Puwen Zhang	10
9	Selective Kv1.5 Blockers: Development of (R)-1-(Methylsulfonylamino)-3-[2-(4-methoxyphenyl)ethyl]-4-(4-methoxyphenyl)-2-imidazolidinone (KVI-020/WYE-160020) as a Potential Treatment for Atrial Arrhythmia 2009 ·Journal of Medicinal Chemistry ·Benjamin E. Blass,Andrew Fensome,Eugene J. Trybulski,Ronald L. Magolda,Stephen J. Gardell,Kun Liu,(unknown),Irene Feingold,Christine Huselton,C. M. Jackson,(unknown),Douglas M. Ho,James K. Hennan,John M. Janusz	16
10	Dual acting norepinephrine reuptake inhibitors and 5-HT2A receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles 2009 ·Bioorganic & Medicinal Chemistry ·(unknown),(unknown),Eric S. Manas,Robert McDevitt,Yanfang Li,Paige E. Mahaney,Albert J. Robichaud,Christine Huselton,Peter D. Alfinito,Jenifer A. Bray,Scott Cosmi,Grace H. Johnston,Thomas Kenney,Elizabeth J. Koury,Richard C. Winneker,Darlene C. Deecher,Eugene J. Trybulski	29
11	Synthesis and activity of novel 1- or 3-(3-amino-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones as selective norepinephrine reuptake inhibitors 2008 ·Bioorganic & Medicinal Chemistry Letters ·Puwen Zhang,Eugene A. Terefenko,Casey C. McComas,Paige E. Mahaney,A. T. Vu,Eugene J. Trybulski,Elizabeth J. Koury,Grace H. Johnston,Jenifer A. Bray,Darlene C. Deecher	14
12	Identification and synthesis of major metabolites of Vasopressin V2-receptor agonist WAY-151932, and antagonist, Lixivaptan® 2007 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Eugene J. Trybulski,Jehan F. Bagli,(unknown),John L. Considine,(unknown),(unknown),William DeMaio,(unknown),(unknown)	10
13	5-(3-Cyclopentyl-2-thioxo-2,3-dihydro-1H-benzimidazol-5-yl)-1-methyl-1H-pyrrole-2-carbonitrile: A novel, highly potent, selective, and orally active non-steroidal progesterone receptor agonist 2007 ·Bioorganic & Medicinal Chemistry ·Puwen Zhang,Eugene A. Terefenko,Jeffrey C. Kern,Andrew Fensome,Eugene J. Trybulski,Ray Unwalla,Jay Wrobel,(unknown),Yuan Zhu,Jeffrey Cohen,Margaret LaCava,Richard C. Winneker,Zhiming Zhang	18
14	Synthesis and activity of a new class of dual acting norepinephrine and serotonin reuptake inhibitors: 3-(1H-indol-1-yl)-3-arylpropan-1-amines 2006 ·Bioorganic & Medicinal Chemistry ·Paige E. Mahaney,A. T. Vu,Casey C. McComas,Puwen Zhang,Lisa Nogle,(unknown),(unknown),Liza Leventhal,Nicole R. Sullivan,Albert J. Uveges,Eugene J. Trybulski	30
15	Control of Chronic Inflammation with Pathway Selective Estrogen Receptor Ligands 2006 ·Current Topics in Medicinal Chemistry ·Robert J. Steffan,Edward Matelan,Mark A. Ashwell,William Moore,(unknown),Eugene J. Trybulski,Christopher C. Chadwick,Susan Chippari,Thomas Kenney,Richard C. Winneker,A Eckert,Lisa Borges-Marcucci,Steven J. Adelman,Xu Zhang,(unknown),Douglas C. Harnish	11
16	Pyridobenzodiazepines: A novel class of orally active, vasopressin V2 receptor selective agonists 2005 ·Bioorganic & Medicinal Chemistry Letters ·Amedeo Failli,(unknown),Robert J. Steffan,(unknown),David Williams,Eugene J. Trybulski,Xiaoping Ning,(unknown),(unknown),David J. Hartmann,Peter S. Chan,(unknown)	37
17	Substituted 4-hydroxyphenyl sulfonamides as pathway-selective estrogen receptor ligands 2005 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Mark A. Ashwell,Eugene J. Trybulski,(unknown),William Moore,Douglas C. Harnish,Christopher C. Chadwick	5
18	The design, synthesis and physical chemical properties of novel human vasopressin V2-receptor antagonists optimized for parenteral delivery 2000 ·Bioorganic & Medicinal Chemistry Letters ·Mark A. Ashwell,Jehan F. Bagli,(unknown),(unknown),(unknown),(unknown),(unknown),John F. Rogers,(unknown),Eugene J. Trybulski,David Williams	10
19	Quinidine preferentially blocks the slow delayed rectifier potassium channel in the rested state. 1996 ·Journal of Pharmacology and Experimental Therapeutics ·Jianan Yao,Eugene J. Trybulski,Gea‐Ny Tseng	12
20	Chemical and biochemical studies of 2-propynylpyrrolidine derivatives. Restricted-rotation analogs of N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide (BM-5) 1990 ·Journal of Medicinal Chemistry ·Eugene J. Trybulski,(unknown),Richard M. Mangano,(unknown)	13

About Eugene J. Trybulski

Eugene J. Trybulski is a scholar working on Organic Chemistry, Toxicology and Cellular and Molecular Neuroscience, having authored 52 papers that have together received 1.1k indexed citations. Recurring topics across this work include Phenothiazines and Benzothiazines Synthesis and Activities (11 papers), Estrogen and related hormone effects (8 papers) and Neurotransmitter Receptor Influence on Behavior (7 papers). The work is most often cited by research in Organic Chemistry (698 citations), Toxicology (23 citations) and Pharmacology (107 citations). Eugene J. Trybulski has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Joseph J. Tufariello, Shaikh A. Ali, G. B. MULLEN, Robert J. Steffan, E. J. Corey, Paige E. Mahaney, Robert Lett, John R. Falck, Peter Sheldrake and Christopher C. Chadwick. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact